Quantitative analysis of 2-hydroxyglutarate as a controversial oncometabolite in malignant gliomas.

Bystricky, P; Kasubova, I; Richterova, R; Lasabova, Z; Kolarovszki, B

Bystricky, P; Kasubova, I; Richterova, R; Lasabova, Z; Kolarovszki, B.

Afiliação

Bystricky P; Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Kasubova I; Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Richterova R; Department of Neurosurgery, University Hospital Martin and Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Lasabova Z; Department of Molecular Biology and Genomics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Kolarovszki B; Department of Neurosurgery, University Hospital Martin and Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.

Neoplasma ; 67(6): 1367-1372, 2020 Nov.

Article em En | MEDLINE | ID: mdl-32853017

Assuntos

Neoplasias Encefálicas/metabolismo; Glioma/metabolismo; Glutaratos/análise; Neoplasias Encefálicas/genética; Glioma/genética; Humanos; Isocitrato Desidrogenase/genética; Mutação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Glutaratos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Glutaratos Idioma: En Ano de publicação: 2020 Tipo de documento: Article